ZYPREXA RELPREVV for Physicians
and Healthcare Providers
ZYPREXA RELPREVV is indicated for the treatment of schizophrenia in adults. Efficacy was established in two clinical trials in patients with schizophrenia: one 8-week trial in adults and one maintenance trial in adults.
Does your patient with schizophrenia need another option?1,2
- History of previous episodes
- Exacerbation of symptoms
For a list of symptoms and the complete diagnostic criteria for schizophrenia, see the Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Text Revision. American Psychiatric Association, 2000.
Learn more about:
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000.
- ZYPREXA RELPREVV full Prescribing Information. Indianapolis, IN: Eli Lilly and Company; 2011.